The Point of Care for Sepsis Diagnostics Market was valued at USD 516.62 million and is projected to reach a market size of USD 1001.64 million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 9.92%.
In the past there was limited availability for testing sepsis, most of them required traditional laboratory testing, which not only consumed a lot of time but also resulted in human errors. However, with the advancement in testing technologies, detecting sepsis became easy and increased consumer demand for POCT diagnostics for sepsis. These included advanced biomarker testing devices or tools, at-home testing kits, and AI-enabled point-of-care devices for analyzing and monitoring patients. Furthermore, compact POCT devices provided convenience and rapid results to both homecare patients and hospitals, resulting in increased efficiency in treatments. Furthermore, the future holds positive for the point of care for the sepsis diagnostics market, as AI is increasingly adopted in hospitals and clinics for testing, analyzing, and monitoring purposes. Moreover, advancements in nanotechnology have led to the development of miniature and handheld POCT devices that can enable quick and early detection of sepsis at the molecular level.
Key Market Insights:
As per WHO, nearly 85% of sepsis cases, including death cases occur in low-resource settings,
Moreover, children account for 49 million cases of sepsis every year.
Furthermore, 27% of people suffering from sepsis were in hospitals in 2022 and 42% of people died in intensive care units (WHO)
As per research published by the National Institute of Health (PubMed), 60% of sepsis cases occur in patients aged 65 years and above.
Point of Care For Sepsis Diagnostics Market Drivers:
Increasing cases of sepsis have boosted the demand for point-of-care sepsis diagnostics in the market.
The increasing incidence of sepsis is the major factor contributing to the demand for POC diagnostics. Sepsis is an infectious disease that damages the immunity system, and in chronic cases can lead to organ failure. Moreover, the disease is more prone to the elderly, as they are at higher risk of developing chronic diseases due to reduced functioning of the body and weak immunity system. Therefore, POC diagnostics devices can help in early detection of sepsis and prevent patients from fatalities such as organ failure, or in severe cases of death. Moreover, as per WHO, sepsis kills 11 million every year, of which children account for the most cases of sepsis Furthermore, biomarker and diagnostic marker tests are at the forefront in diagnosing the severity of sepsis and analyzing the pathogen that helps in developing a targeted treatment for it. Moreover, the compact and portable structure of POC diagnostics devices enables testing even at remote places, in ambulances, emergency and intensive care units, and others.
The rising geriatric population has boosted the demand for point-of-care for sepsis diagnostics in the market.
The rapidly aging population is the major reason for the increase in the number of sepsis, as aged people have weak immune systems, which becomes a prime cause of chronic diseases, such as sepsis. Moreover, aged people already suffering from other illnesses such as diabetes, are at high risk of developing sepsis. Therefore, there is an increase in demand for POC diagnostics devices that detect sepsis for immediate treatment procedures. Most common among these testing requirements are homecare testing kits such as bedside testing, which allow caregivers or family members of the elderly to analyze and monitor the severity of sepsis and seek immediate treatment from doctors.
Point of Care For Sepsis Diagnostics Market Restraints and Challenges:
Data privacy issues in smart POCT diagnostics can decline its demand in the market. Smart POCT devices contain patients’ data on online software, which is exposed to cyber threats such as data leaks, misuse of data, or privacy leaks, resulting in reduced safety of patients.
Some POCT devices, especially at-home care devices with complex structures and functioning can be difficult to handle, resulting in inaccurate or faulty results. This can decline the demand for point-of-care for sepsis diagnostics in the market.
Point of Care For Sepsis Diagnostics Market Opportunities:
The Point of Care For Sepsis Diagnostics Market is anticipated to deliver lucrative opportunities for businesses, which include acquisitions, partnerships, collaborations, product launches, and agreements during the forecasted period. Furthermore, the growing prevalence of sepsis, especially among the elderly and children, and rising demand for on-site and convenient diagnosis is predicted to develop the market for the point of care for sepsis diagnostics and enhance its future growth opportunities.
POINT OF CARE FOR SEPSIS DIAGNOSTICS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
9.92% |
|
Segments Covered |
By Diagnostic Method, End-User, Pathogen, Age, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Siemens, Abbott, AdvanDx, Miacom Diagnostics, Biofire Diagnostics, Alteco Medical, Becton Dickinson, Wolters Kluwer, Immunexpress, Inflammatix, Mbio, Abionic |
Biomarker Test
Molecular Diagnostics
Immunoassays
Others
In 2022, based on market segmentation by diagnostic method, biomarker tests occupied the highest share of about 25.5% in the market. Biomarker tests for sepsis include measuring specific markers in the patient’s blood and then analyzing the presence of sepsis. Moreover, the most commonly used biomarkers are procalcitonin, C-reactive protein, cytokines, and others. Furthermore, the growth of this segment is attributed to increased efficiency and rapid delivery of results that help in devising treatment solutions for sepsis and analyzing patient’s responses to these solutions.
Molecular diagnostics is the fastest-growing segment during the forecast period. Molecular diagnostics helps in detecting pathogens causing sepsis in the patient’s body through genetic diagnosing. This method usually involves DNA or RNA sequencing for understanding the presence of pathogens and devising treatment procedures based on the results obtained. Moreover, the technique helps in delivering faster results by analyzing blood samples, urine, cerebrospinal fluid, and others. Furthermore, these can use portable or compact devices such as blood analyzers, and others.
Hospitals & Clinics
Homecare
Research Laboratories
Others
In 2022, based on market segmentation by end-users, hospitals & and clinics occupied the highest share of about 32% in the market. Hospitals & clinics are major users for diagnosing onsite sepsis using various devices, that provide immediate testing and diagnosing of sepsis patients. Moreover, this enables healthcare professionals to perform immediate treatment based on the results obtained. Additionally, many hospitals use POC monitoring devices that monitor patient’s progress and response to specific treatments or drugs, thereby assisting doctors in devising immediate interventions in emergency cases.
The homecare segment is the fastest-growing segment during the forecast period. Post-pandemic, there is an increasing trend in homecare testing and monitoring, which has increased the demand for POC homecare diagnostic devices for sepsis that enable individuals to perform tests that can detect early signs of infections. Moreover, POC diagnostic devices equipped with telemonitoring and teleconsultation services enable individuals to share their reports with doctors for further treatment procedures. In addition, these devices allow mobile app integration that allows medical professionals to remotely monitor patient’s health, including geriatric patients that are more exposed to diseases such as sepsis.
Bacteria
Fungal
Viral
In 2022, based on market segmentation by pathogen, bacteria occupied the highest share of about 30% in the market. Bacteria sepsis diagnostics focuses on diagnosing the presence of common bacteria found in sepsis such as staphylococcus aureus, E. coli, Klebsiella pneumoniae, and others. Moreover, devices used for testing bacteria involve using blood culture systems, molecular diagnostic devices, rapid testing tools, sensitivity testing, and others.
The viral segment is the fastest-growing during the forecast period. These include performing diagnosis for analyzing the virus severity in sepsis, such as viruses that can directly or indirectly lead to sepsis (adenoviruses, influenza viruses, herpes simplex virus, and others). Furthermore, common diagnostic techniques used are collecting DNA or RNA samples of patients for performing nucleic acid testing, biomarker/diagnostic marker testing, serological testing, and others.
Pediatric
Adult
Geriatric
In 2022, based on market segmentation by age, geriatric occupied the highest share of about 36% in the market. Sepsis has been diagnosed as a disease of the elderly since they are more prone to medical conditions that lead to sepsis. These include respiratory conditions, diabetes, obesity, immunodeficiency viruses, and others. Furthermore, as per research published by the National Health Institute (PubMed), sepsis-related mortality accounted for 80% of patients aged 80 years. This has further raised the demand for POC diagnostics that enable family members of the elderly to perform at-home tests and remotely monitor their health them.
Pediatric is the fastest-growing segment during the forecast period. Children too, especially kids aged below 14, and infants develop sepsis due to an injury, inflammation, infection, or an already existing disease, which is left untreated. POC diagnostics help in early detection of sepsis in children and minimize the risk of future damage helping healthcare professionals in devising preventive treatment procedures.
North America
Europe
Asia-Pacific
South America
Middle-East & Africa
In 2022, based on market segmentation by region, North America occupied the highest share of about 38% in the market. The presence of technologically advanced diagnostic devices along with robust healthcare infrastructure has contributed to the demand for point-of-care for sepsis diagnostics in the region.
Asia-Pacific is the fastest-growing region during the forecast period. Increasing demand for on-site diagnosis in hospitals and clinics, growing trends in telehealth and telemedicine, and increasing government support for the healthcare sector in the form of grants and investment expenditure have contributed to the demand for point-of-care for sepsis diagnostics in the region.
COVID-19 Impact Analysis on the Point of Care For Sepsis Diagnostics Market:
The pandemic had a significant impact on the point of care for the sepsis diagnostics market. The market witnessed increased demand for POC diagnostics for detecting diseases due to the risks posed by the virus outbreak. Sepsis being an infectious disease, witnessed an increased amount of testing requirements by hospitals and healthcare units, as the virus outbreak resulted in further damage to the body, and sepsis is one of them. However, the shortage of healthcare services and shifted focus towards treating virus-infected patients during the pandemic resulted in declined demand for POCT for sepsis diagnostics in the market. However, increased digitization during the pandemic helped the healthcare sector overcome the disadvantage caused by to shortage of healthcare services by adopting telehealth and telemedicine services, which helped to bring down the delay in treating patients during the pandemic.
Latest Developments:
The market for point of care for sepsis diagnostics is witnessing increased demand due to constant product innovations, rising consumer demand for early detection and rapid delivery testing devices; and rising trends in telehealth in the market.
In November 2022, Immunexpress launched a rapid testing device for sepsis called – SepiCyte Rapid. The products test sepsis directly from the blood draw in a day, thus facilitating fast diagnosis of sepsis. Moreover, the product uses PCR technology to detect mRNA signatures in the blood sample and evaluate the severity of bacteria or other pathogens causing the infection.
Key Players:
Siemens
Abbott
AdvanDx
Miacom Diagnostics
Biofire Diagnostics
Alteco Medical
Becton Dickinson
Wolters Kluwer
Immunexpress
Inflammatix
Mbio
Abionic
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Point of Care for Sepsis Diagnostics Market was valued at USD 516.62 million and is projected to reach a market size of USD 1001.64 million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 9.92%.
Increasing cases of sepsis and the Rising geriatric population are the market drivers of the Point of Care For Sepsis Diagnostics market.
Biomarker Tests, Molecular Diagnostics, Immunoassays, and Others, are the segments under the Point of Care For Sepsis Diagnostics Market by diagnostic method.
North America is the most dominant region for the Point of Care For Sepsis Diagnostics Market.
Asia-Pacific is the fastest growing region in the Point of Care For Sepsis Diagnostics Market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
